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A three-month-old female Rottweiler puppy was referred for intravascular correction of a previously identified
cor triatriatum dexter. Echocardiography confirmed the presence of a hyperechoic membrane that divided the
right atrium into a cranial and caudal chamber. A foramen in this membrane allowed the blood to flow from the
caudal to the cranial chamber. Balloon dilation of the defect under transthoracic echocardiographic guidance was
scheduled for the following day. The dog was premedicated with 0.5 μg/kg sufentanil and 0.2 mg/kg midazolam
administered intravenously. General anaesthesia was induced with 2 mg/kg propofol and maintained with inhaled
isoflurane in oxygen; at the same time, a constant rate infusion of 0.5 μg/kg/h sufentanil was administered by
means of an infusion pump. Uneventful ventricular and supraventricular tachyarrhythmias developed during the
placement of catheters and balloon dilation. At the end of procedure, when the guide wire and balloon catheter
were removed, normal sinus rhythm was observed. To the authors’ knowledge, no previous reports have described
the anaesthetic management of a balloon dilation procedure for cor triatriatum dexter in dogs.
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Cor triatriatum dexter (CTD) is a rare congenital defect
caused by the failure of the right sinus venosus valve to
regress during embryogenesis [1]. The persistent mem-
brane causes the division of the right atrium into a cra-
nial and caudal chamber. Anatomic variations of CTD
may be distinguished from the location of the inlet of
the coronary sinus, which can enter either the cranial or
the caudal chambers. The intra-atrial septum may be
imperforate or perforate to varying degrees, resulting in
hepatic congestion and ascites due to the mechanical
obstruction of the blood flow through the caudal vena
cava toward the right atrium [1]. Two techniques have
been reported to treat CTD in dogs: surgical membrane
resection [2–7] or percutaneous balloon dilation [8, 9].
To the authors’ knowledge, no previous reports have
described the anaesthetic management of a balloon dila-
tion procedure for CTD in dogs. This report discusses
the anaesthetic protocol used and the impact of balloon
dilation on the cardiovascular system.* Correspondence: valedemo@inwind.it
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A three-month-old female Rottweiler puppy, weighing
11.6 kg, was referred to the cardiology service of the
Veterinary Teaching Hospital of Perugia University, Italy
for further assessment and treatment of CTD. When
presented to the referring veterinarian, the dog had a
history of gradual abdominal enlargement over the
previous weeks. CDT was diagnosed by transthoracic
echocardiography and medical treatment included fur-
osemide(2 mg/kg orally twice daily), spironolactone
(2 mg/kg orally once daily), and ramipril (0.25 mg/kg or-
ally once daily). On clinical examination, the dog was
bright and alert with a heart rate (HR, beats/min) of 136
and a respiratory rate (RR, breaths/min) of 36, but
showed poor body condition (body condition score 3/9)
and a markedly enlarged abdomen with a fluid wave.
Abdominal ultrasound revealed severe ascites associated
with evident hepatomegaly and hepatic venous conges-
tion. Abdominocentesis revealed modified transudate as-
citic fluid (specific gravity 1020, total protein 2.2 g/dL,
poor cellularity). Cardiac auscultation revealed no heart
murmur or arrhythmia.
Transthoracic echocardiography5 showed a thin,
hyperechoic membrane that divided the right atriums article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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cranial vena cava inlet, and right auricle were included
in the cranial chamber, whereas the caudal chamber
included the caudal vena cava inlet and the coronary
sinus. A 4.5 mm opening allowed the blood to flow
from the caudal to the cranial chamber. A colour
Doppler5 examination showed turbulent flow from the
caudal to the cranial chamber of the right atrium
across the anomalous membrane, with a peak velocity
of approximately 2.2 m/sec.
From these findings, CTD was confirmed and correc-
tion of the anomalous membrane by a balloon dilation
technique was scheduled for the following day.
Hematologic parameters had revealed alterations in both
blood count and in biochemical analysis (Table 1).
Prior to the anaesthetic procedure, the two cephalic
veins were aseptically catheterized with a 20 gauge can-
nula. Patient preoxygenation (flow-by: 5 L/min of pure
oxygen) was allowed before and after premedication.
Pre-anaesthesia included consecutive intravenous (IV)
administration of 0.5 μg/kg sufentanil and 0.2 mg/kg
midazolam. Five minutes after premedication, general
anaesthesia was induced with 2 mg/kg propofol, admin-
istered as a single, progressive IV bolus. The dog’s tra-
chea was intubated with a 6.5 mm cuffed tube, which
was connected to a non-rebreathing system (Bain-type).
General anaesthesia was maintained with isoflurane di-
luted in oxygen (fresh gas flow: 3 L/min); concurrently, a
constant rate infusion (CRI) of 0.5 μg/kg/h sufentanil9
and 5 mL/kg/h of lactated Ringer’s solution were admin-
istered IV by infusion pumps.
When an adequate depth of anaesthesia was achieved,
the dog was positioned in right lateral recumbency for
the cardiovascular corrective procedure. The patient was
allowed to spontaneously breathe during the entire an-
aesthetic procedure and did not required artificial venti-
lation support.Table 1 Altered hematologic parameters in a dog undergoing
balloon dilation of cor triatriatum dexter
Parameter Value Normal range
Hct (%) 28 37–55
Hb (g/dL) 9.84 12–18
RBC (M/μL) 4.68 5.50–8.50
MCV (f/L) 56.5 60–77
RDW (%) 8.6 12–16
TP (g/dL) 3.93 5.5–7.8
Alb (g/dL) 2.5 2.6–3.8
Urea (mg/dL) 49.7 10–45
Ast (U/L) 50 10–40
Hct hematocrit, Hb haemoglobin, RBC red blood cell, MCV mean cell volume,
RDW high red blood cell distribution width, TP total protein, Alb albumine,
Ast aspartate transaminase enzymesA 24 gauge cannula was aseptically inserted into the
metacarpal artery to measure direct blood pressure. HR,
RR, electrocardiogram (ECG), invasive arterial blood
pressure (systolic arterial pressure, diastolic arterial pres-
sure, mean arterial pressure (MAP); mmHg), haemoglobin
oxygen saturation (SpO2, %), end-tidal carbon dioxide par-
tial pressure (EtCO2, mmHg), end-tidal isoflurane concen-
tration (EtIso, %), and rectal temperature (T,°C) were
continuously monitored and recorded every 5 min. During
inflation and deflation of the balloon catheter (BC), the
same parameters were recorded every 2 min. The trans-
ducer was zeroed at the level of the manubrium of the
sternum.
The interventional procedure included percutaneous
access from the right femoral vein by the Seldinger tech-
nique [10] and the subsequent positioning of two bal-
loon valvuloplasty catheters20 (first 12 mm and then
22 mm) across the intra-atrial membrane, under trans-
thoracic echocardiography guidance5. Ten consecutive
hand inflations with a 12 mm BC20 were performed. The
dilation procedure was then repeated by using a 22 mm
BC20.
The HR from the beginning to the end of the anaes-
thesia ranged from 126 to 163 and the MAP from 62 to
82 (Fig. 1). Table 2 shows the values of RR, SpO2, EtCO2,
EtIso, and T. During the interventional procedure, sev-
eral arrhythmias were noted and recorded (ventricular
and supraventricular tachyarrhythmias). Transient sup-
raventricular extrasystoles were observed during the
placement of the guide wire and BC20, but spontan-
eously resolved following the withdrawal of the dilation
instrumentations from the atrial wall. During balloon in-
flations (22 mm BC20), ventricular and junctional beats
(Fig. 2) and non-sustained supraventricular tachycardia
(Fig. 3) occurred, with spontaneous conversion to sinus
rhythm after the end of the dilation procedure. These ar-
rhythmias did not show any haemodynamic impact on
the arterial pressure.
Table 3 provides the total anaesthesia and cardiovascu-
lar procedure time, the total inflation-deflation time of
the BC20, the number of BC20 inflations, and the total
dose and CRI time of sufentanil9.
The dog was extubated 9 min after the end of the an-
aesthesia and was able to stand after 14 min. The recov-
ery was uneventful and the patient was hospitalized
post-operatively for two days.
Conclusions
Although a definitive conclusion cannot be made from a
single case, the balanced anaesthesia used for the three-
month-old puppy described in this report assured good
patient haemodynamic stability for the safeness of this
minimal invasive balloon dilation technique. The side ef-




























Fig. 1 Heart rate (HR, beats/min) and mean arterial pressure (MAP, mmHg) values of the dog undergoing balloon dilation for cor triatriatum
dexter at Baseline (b, 15 min before the skin incision), at Skin incision (si) and every 10 minutes until the start of the balloon inflation-deflation
(a), when the same parameters are reported every 2 minutes until the end of the procedure (c) (End, 15 min after the end of the cardiovascular
procedure)
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tional beats, did not have any haemodynamic impact and
disappeared as soon as the wires were removed from the
heart. Antiarrhythmic therapy was therefore not required.
During an interventional procedure, anaesthesia should
ensure hypnosis, analgesia, and haemodynamic stability; ti-
tration should be easy and reliable in order to cope with
rapidly changing loading conditions and intense, but short-
lived, haemodynamic disturbances [11]. The anaesthetic
drugs should not interfere with the electrophysiological
processes in the cardiac conduction system and, above all,
anaesthetic recovery should be fast and free of side effects
[11]. Furthermore, puppies under anaesthesia are more
likely to develop hypotension, hypothermia, hypoglycaemia,
and hypoxia [12, 13]. For these reasons, management of the
anaesthesia for a paediatric dog undergoing an interven-
tional procedure is extremely critical. In addition to these
fundamental principles, anaesthetists dealing with a patient
with CTD must also follow the haemodynamic principlesTable 2 Physiological parameters for a balloon dilation of cor
triatriatum dexter in a dog under general anaesthesia
Baseline b-CBI C (range) CBI (range) End
RR (breaths/min) 26 22–30 23–27 12
SpO2 (%) 95 92–100 94–95 98
EtCO2 (mmHg) 38 37–41 39–45 37
EtIso (%) 1.2 1.1–1.2 1.1–1.2 1.3
T (°C) 36.5 35.9–36.5 35.6–35.9 35.2
Baseline 15 min before the skin incision, End 15 min after the end of the
procedure, CB catheter balloon, b-CBI form Baseline to the beginning of CB
inflation, CBI during CB inflation, RR respiratory rate, SpO2 haemoglobin
oxygen saturation, EtCO2 end-tidal carbon dioxide partial pressure, EtIso end-
tidal isoflurane concentration, T rectal temperatureused to manage patients with tricuspid stenosis: avoid
tachycardia, avoid hypotension by maintaining euvolemia,
and avoid increases in pulmonary vascular resistance [14].
The veterinary literature lacks information about the
anaesthesia strategy, the interactions of drugs and the
repercussions for the patient, and the possible cardiovas-
cular impact of the drugs chosen in dogs affected by
CTD who are undergoing balloon dilation of the defect.
Some reports indicate only which anaesthetic drugs were
used [8, 9, 15, 16]. In our case, the dog was sedated with
a combination of a potent opioid (sufentanil) and mid-
azolam in order to preserve the cardiovascular function
of the patient [17, 18]. Premedication is a crucial phase
of anaesthesia for a veterinary patient; it can calm the
animal and decrease the amount of induction and
maintenance drugs that are needed [19]. Mild sedation
is desirable to prevent excitement during anaesthetic
induction and to avoid excess sympathetic tone, which
can cause cardiac arrhythmia or ventricular fibrillation
[20, 21].
Opioids are the preferred agents in critically ill pa-
tients because of the minimal effect of these agents on
cardiac output (CO), systemic blood pressure, and oxy-
gen delivery. They also provide analgesic and sedative ef-
fects that can be reversed with naloxone, if necessary
[22]. Generally speaking, however, at high dosages, they
cause bradycardia mediated via a vagal mechanism [21]:
a slowing of HR in puppies results in decreased CO due
to the limited capacity of the heart to increase cardiac
stroke volume [13]. These side effects must always be
carefully weighed against their benefits, particularly in
terms of sedation and analgesia. Atropine, an anticholin-
ergic drug used to decrease respiratory tract secretions
Fig. 2 Electrocardiographic findings in a dog with CTD during the 3d balloon inflation (22 mm balloon catheter). The trace reveals atrial (QRS
complex similar to a sinus complex), ventricular (wide QRS complex followed by a large T wave) and junctional beats (QRS complex similar to a sinus
complex and a negative P wave). The atrial beats are followed by ventricular beats, and junctional beats occurred when the balloon slipped distally against
the tricuspid valve. Lead II tracing; Speed 25 mm/s; amplitude 10 mm/mV
De Monte et al. Acta Veterinaria Scandinavica  (2015) 57:29 Page 4 of 7and to treat bradyarrhythmias, was not included in our
protocol because of its intrinsic arrhythmogenic poten-
tial [23, 24] and the probable tachyarrhythmias that the
procedure itself could have caused [9, 15, 16].
Benzodiazepines such as midazolam and diazepam are
unreliable anxiolytics when given alone, unless the ani-
mal has central nervous system depression; however,
they are able to provide improved sedation when given
in combination with opioids and dissociatives [22]. Fur-
thermore, young puppies, unlike adult dogs, are more
susceptible to the sedative effects of benzodiazepines.
Acepromazine, a phenothiazine derivate, is largely
used as a sedative in dogs, but its tendency to cause mild
hypotension by blocking α-1 receptors and its long half-
life made it unsuitable for use in our case. Alpha-2 ago-
nists (e.g. dexmedetomidine, medetomidine) are excel-
lent sedatives and anxiolytics, but significantly affect
cardiovascular function. The main negative cardiovascu-
lar effects of these drugs include bradycardia with pos-
sible bradyarrhythmias (atrioventricular heart block and
ventricular escape rhythm) and a dramatic reduction in
CO caused by reduced central sympathetic tone. These
molecules also cause an increase in systemic vascular re-
sistance (peripheral action on α-2 receptors) and hyper-
tension, which induces a reflex baroreceptor-mediated
physiologic bradycardia and marked reduction in CO,
further perpetuated by the central effects of sedation
and reduced sympathetic tone [17, 25]. Healthy paediat-
ric patients have limited stroke volume and cardiac re-
serve, and CO is dependent on HR [13]; therefore, this
class of drugs, which causes bradycardia and a decrease
in CO, was not considered for the anaesthetic manage-
ment of this puppy. Furthermore, the cardiovascular
procedure itself could cause arrhythmias, and so these
drugs were excluded from the protocol.
Ideally, after the clinical effect of premedication, a slow
transition to general anaesthesia should occur to allowFig. 3 Electrocardiographic findings in a dog with CTD during the last ball
sustained supraventricular tachycardia (duration 6 s) with a rate of 250 beatime for the cardiovascular and nervous system to ap-
propriately respond to and accommodate the medica-
tions [26]. Propofol is a hypnotic agent, which, because
of its multiple routes of elimination and its smooth in-
duction, especially for recovery, is most commonly used
for paediatric patients to induce general anaesthesia [21,
27, 28]. Cardiovascular changes induced by propofol
administration consist of a slight decrease in arterial
blood pressures (systolic, mean, diastolic) without a
compensatory increase in HR, and so the dose of propo-
fol should always be carefully titrated against the needs
and responses of individual patients, as their anaesthetic
requirements vary considerably [28]. In our case, the
dog required a low dose of propofol for the induction of
general anaesthesia. Propofol binds strongly to serum
protein (97–98 %); hence, in this specific puppy, hypo-
proteinaemia (hypoalbuminaemia and hypohaemoglobi-
nemia) resulted in an increase of the unbound drug in
the circulation (i.e. the active part of the drug), which
may have been further increased by the strong protein
binding of the other drugs used for premedication. Thus,
we can assume that the poor clinical condition of the
patient contributed to a lower than expected volume
of distribution and, therefore, in a higher serum drug
concentration. These possible contributing factors,
added to the effects of premedication, probably justify
the low dose of propofol used for induction of general
anaesthesia.
All volatile inhalation anaesthetics cause dose-
dependent and drug-specific changes in cardiovascular
performance: decreased arterial blood pressure, stroke
volume, and peripheral vascular resistance. The newer
volatile anaesthetics tend to preserve CO at clinically
useful concentrations [29, 30]. A major advantage of
these newer agents (sevoflurane, desflurane) is their
superior pharmacokinetic properties, including low
solubility in blood and tissues [31], resulting in a fasteroon inflation (22 mm balloon catheter). The trace shows a non-
ts/min. Lead II tracing; Speed 25 mm/s; amplitude 10 mm/mV
Table 3 Anaesthetic protocol and details of cardiovascular
procedure for a balloon dilation of cor triatriatum dexter
in a dog
Premedication Sufentanil (0.5 μg/kg) + Midazolam
(0.2 mg/kg)
Induction Propofol (2 mg/kg)
Maintenance Isoflurane in O2 + Sufentanil CRI
(0.5 μg/kg/h)
Total anaesthesia time 117 min
Total cardiovascular procedure time 62 min
Total time of the inflation-deflation
of the BC
12 min
Number of balloon inflations 20; 10 (12 mm BC) + 10
(22 mm BC)
Total sufentanil CRI time 97 min
Total dose of sufentanil 15.1 μg
BC balloon catheter, CRI constant rate infusion
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depth of anaesthesia [32]. However, recent veterinary
literature lacks clear evidence of better clinical per-
formance for sevoflurane and desflurane, compared
with isoflurane, in non-critical dogs and cats. Further-
more, both isoflurane and sevoflurane are used in
cardiac surgery in humans, resulting in a similar cardi-
oprotective effect [33, 34].
Sufentanil decreases the minimum alveolar concentra-
tion (MAC) of volatile anaesthetics [35, 36]. In our case,
isoflurane end tidal concentration was maintained
mostly below 1 MAC (1 MAC = 1.28 vol.%), resulting in
good haemodynamic stability (Table 2). Moreover, sufen-
tanil and other potent opioids can have a cardioprotec-
tive and antiarrhythmic effect mediated by diverse
intracellular signalling pathways and indirect effects [37,
38]. Indeed, this specific μ-opioid receptor agonist is
largely used for cardiac surgery anaesthesia in children
[39, 40]. On the other hand, the possible occurrence of
bradycardia due to vagal stimulation is an undesirable event
in a puppy because of the negative effect that bradycardia
may have on CO. Little information has been reported in
the literature about pain during minimally invasive vascular
procedures. Portmans asserts that the inflation of the bal-
loon (e.g. dilation of a stenotic valve) can cause pain, which
is essentially acute and intense, but short-lived [11]. Thus,
the reasons for choosing the potent opioid sufentanil for
the management of anaesthesia include its halogen-
sparing effects, its cardioprotective and analgesia effects
during inflation of the balloon in the atrium, and the
possibility of controlling undesirable bradycardia with the
administration of atropine.
The puppy in this report, despite having hypoproteinae-
mia, an obstructed venous return, and an extremely tense
abdomen, did not require any drugs to support cardiovas-
cular function, because the physiological parameters werewithin normal ranges throughout the entire procedure.
Hypoproteinaemia usually causes an increase in the active,
unbound plasma concentration of drugs, and thus patients
with this condition should be treated cautiously, as they
are more prone to develop side effects from a relative
overdose [41]. Hypoproteinaemia can also affect oncotic
pressure, making the dog more prone to hypovolemia and
hypotension [42].
The use of spontaneous ventilation in our patient was
suggested for two main reasons: 1) Patients undergoing
minimally invasive procedures usually do not require a
surgical plane of anaesthesia and therefore most of the
time do not easily adapt to the ventilator unless more
anaesthetic drug or a neuromuscular blocker is adminis-
tered; and 2) positive pressure ventilation may interfere
with cardiovascular function, especially in haemodynam-
ically compromised patients, whereas spontaneous venti-
lation may better preserve venous return because of
negative intrathoracic pressure during inspiration [43].
In any case, positive pressure ventilation should always
be available and ready to be used in case the patient’s
condition deteriorates.
During CTD dilation, atrial fibrillation, atrial flutter,
and ventricular and supraventricular tachyarrhythmias
have been reported in dogs [9, 15, 16]. One minute of
cardiac arrest, successfully treated with internal cardiac
massage and adrenaline injection, was described during
the surgical treatment of CTD in a dog [7]. Although
tachyarrhythmias appear to be most frequent, many
types of arrhythmias may occur (atrioventricular block,
tachy-bradyarrhythmias, cardiac arrest) [16, 44–46], and
so the authors considered it more appropriate to admin-
ister the correct antiarrhythmic drug when needed, ra-
ther than administering it preventively.
In our case, supraventricular extrasystoles observed
during the placement of the guide wire or balloon cathe-
ters were likely due to the contact of the catheter tip
with the atrial wall. Supraventricular tachycardia oc-
curred during balloon inflation as a consequence of
atrial membrane and wall stretching. Ventricular and
junctional beats were recorded when the balloon slipped
distally to the membrane against the tricuspid valve dur-
ing inflation. The fact that arrhythmias disappeared and
baseline cardiovascular and respiratory parameters re-
sumed at the end of the procedure suggests that these
side effects were caused by the mechanical action of the
catheters and guide wire on the cardiac structures
(Table 3). Despite the numerous arrhythmias, the inva-
sive blood pressure values did not show any major varia-
tions during balloon inflation (Fig. 1), probably because
each individual dilation was brief (3–5 s) and because a
20- to 30-s pause was guaranteed between inflations in
order to allow the blood to flow through the cardiac
chambers.
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gist and anesthesiologist is the basis of patient manage-
ment; on request by the anesthesiologist, displacement of
the intracardiac catheter by even a few millimeters led to
total interruption of the arrhythmias.
Although the arrhythmias recorded in our case report
were benign and might be explained by the contact of
the catheters and guide wire on the endocardial wall, it
must be emphasized that the supraventricular and ven-
tricular arrhythmias may place the patient at higher risk
for development of malignant arrhythmias. Therefore,
anti-arrhythmic drugs (e.g. lidocaine, esmolol, atropine)
and a defibrillator must be available during the interven-
tional procedure. Lidocaine IV via bolus or CRI has been
used to provide perioperative antiarrhythmic effects and
has been assessed as advantageous for dogs undergoing
balloon valvuloplasty for pulmonic stenosis [47].
Our findings are in complete agreement with those de-
scribed in the literature regarding the occurrence of ar-
rhythmias and their spontaneous resolution following
withdrawal of the catheters. The protocol described in
this case report resulted in good management of anaes-
thesia and analgesia, as well as a fast, smooth, and
uneventful recovery. Although in particular cases, it is
highly recommended to tailor the anaesthetic protocol
to the individual patient’s clinical condition, the protocol
described in this case can be considered a valid basic ap-
proach to be adapted as necessary; moreover, considerable
attention should be given to arrhythmias that develop dur-
ing the procedure to provide timely intervention.
Endnotes
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4Vasotop P; MSD Animal Health S.r.l., Latina, Italy
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10Midazolam I.B.I.; Hospira, Lake Forest, IL, USA
11Proposure 1 %; Merial S.p.A., Milano, Italy
12Rüsch® 6.5 mm endotracheal cuffed tube; Teleflex
Medical S.r.l., Monza e della Brianza, Italy
13Infant T-piece anaesthetic breathing system; Inter-
surgical S.p.A., Modena, Italy
14Excel 210; Ohmeda, Madison, WI, USA
15Isoflurane-Vet; Merial, Milano, Italy
16Ringer Lattato; S.A.L.F S.p.A., Bergamo, Italy
17SK500II sirynge pump; Foschi S.r.l., Roma, Italy
18Delta ven® 1 G 24; Delta Med SPA, Mantova, Italy
19Multiparameter Monitor HB100; Foschi, Roma, Italy20Tyshak II® balloon valvuloplasty catheter; Infiniti
Medical, LLC™, West Hollywood, CA, USA
21DPT-6000; Codan srl, Modena, Italy
22Rosen Wire; Infiniti Medical, LLC™, West Holly-
wood, CA, USA
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